Fairvalue-Calculator Fairvalue-Calculator
EN DE

NAU IB Capital (293580) Fair Value & Analysis

Financial Services · KR · Market cap 157B KRW

Price1,343 KRW
Fair Value1,036 KRW
Upside-22.9%
Quality95/100
Evidence: High Range 776.76 KRW – 1,295 KRW

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

NAU IB Capital (293580) currently trades at 1,343 KRW, while our model-based Fair Value estimate is 1,036 KRW — implying the stock looks roughly 22.9% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

NAU IB Capital operates as a technology business finance company in South Korea. It provides funds and management services to venture companies. The company was founded in 2003 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is NAU IB Capital (293580) undervalued?
As of Jun 26, 2026, our model estimates a fair value of 1,036 KRW versus a price of 1,343 KRW — about −23% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 293580?
Our 21-model fair value for NAU IB Capital is 1,036 KRW (as of Jun 26, 2026), built from audited fundamentals. The current price is 1,343 KRW.
What is the quality score of 293580?
NAU IB Capital has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.